COVID-19 Vaccine Covaxin Neutralises Double Mutant Strain In India: Research Body ICMR

COVID-19 Vaccine Covaxin Neutralises Double Mutant Strain In India: Research Body ICMR

ndtv.com

Made-in-India COVID-19 vaccine, Covaxin, neutralises multiple variants of SARS-CoV-2 COVID-19 virus

Made-in-India COVID-19 vaccine, Covaxin, neutralises multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well, the Indian Council of Medical Research (ICMR) said today.

Bharat Biotech's Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the world with another 60 in the process.

"ICMR study shows Covaxin neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well," the ICMR tweeted.

ICMR-National Institute of Virology has successfully isolated and cultured multiple variants of concern of SARS-CoV-2 virus: B.1.1.7 (the UK variant), B.1.1.28 (Brazil variant ) and B.1.351 (South Africa variant).

Disclaimer: This is an automatically aggregated article/story by a computer program and has not been created or edited by Newsdig.in.

World COVID19 Meter

163370597

Cases

143370992

Recovered

3384049

Deaths
Last updated: GMT
Advt
Advt
Advt
sitemap Disclaimer
Newsdig.in 2019